Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 28Active not recruiting 7Terminated 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 1Liver Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 222pembrolizumab 199Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 154Docetaxel 140Rituximab 137Radiotherapy 137Bevacizumab 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × veliparib × Clear all
NCT01205828 2025-02-12

ABT-888 and Temozolomide for Liver Cancer

Georgetown University

Phase 2 Terminated
16 enrolled 11 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02470585 2024-10-26

VELIA

AbbVie

Phase 3 Terminated
1,140 enrolled 29 charts
Gynecologic

Ovarian Neoplasms

NCT02412371 2020-07-22

A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)

AbbVie

Phase 1/2 Terminated
48 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡